Corner Therapeutics
0 followers
‌
Corner is pioneering a new class of immunotherapies. Our versatile dendritic cell hyperactivation (hDC) platform is unique in its ability to address a virtually unbounded range of cancers and infectious diseases. Our platform technology induces exceptional memory T cell responses that provide robust... Read more
Industries
+1
Headquarters
Employees
Links
Org chart
Steven Altschuler
Collapse
Sivan Elloul
VP Of R&d
Laura Brandano
Vice President, Operations
Andrew Cornforth
Chief Technology Officer
Andrew Bellinger
Co-founder
Jeff Karp
Co-founder
Jonathan Kagan
Co-founder
